Intra-Cellular Therapies - 48 Year Dividend History | ITCI

Historical dividend payout and yield for Intra-Cellular Therapies (ITCI) since 1971. The current TTM dividend payout for Intra-Cellular Therapies (ITCI) as of June 14, 2019 is $0.00. The current dividend yield for Intra-Cellular Therapies as of June 14, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.690B $0.000B
Intra-Cellular Therapies Inc. is a biopharmaceutical company. The company develops drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the central nervous system. Its product candidates include ITI-007, ITI-002 and ITI-009 which is in clinical trials. Intra-Cellular Therapies Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83